With several high-quality serological assays for SARS-CoV-2 now available, the key challenge in using them to help people return to ‘normal life,’ write Florian Krammer and Viviana Simon in this Perspective, will be to apply them in a strategic manner — one that considers their unique sensitivity and specificity levels, acknowledges the questions they don’t yet answer, and more.
- Predicts the onset of Alzheimer’s Disease (AD) using deep learning-based Splice-AI
- When foams collapse (and when they don’t)
- Oahu marine protected areas offer limited protection of coral reef herbivorous fishes
- Picture books can boost physical activity for youth with autism
- Atherosclerosis can accelerate the development of clonal hematopoiesis, study finds